Literature DB >> 25623201

Gastric cancer. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer.

Claire Greenhill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25623201     DOI： 10.1038/nrgastro.2015.9

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.

Authors:  Choong-kun Lee; Minkyu Jung; Inkyung Jung; Su Jin Heo; Yong Hyu Jeong; Ji Yeong An; Hyoung-Il Kim; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh; Hyo Song Kim; Sun Young Rha; Hyun Cheol Chung
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969
  1 in total
  10 in total

1.  Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy.

Authors:  Xinhua Chen; Yuehong Chen; Tao Li; Luo Jun; Tian Lin; Yanfeng Hu; Huilin Huang; Hao Chen; Hao Liu; Tuanjie Li; Guoxin Li; Jiang Yu
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

Review 2.  Metformin: A Hopeful Promise in Aging Research.

Authors:  Marta G Novelle; Ahmed Ali; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

3.  Metformin potentiates rapamycin and cisplatin in gastric cancer in mice.

Authors:  Guanzhen Yu; Wenzheng Fang; Tian Xia; Ying Chen; Yunshu Gao; Xiaodong Jiao; Suyun Huang; Jiejun Wang; Zhaosheng Li; Keping Xie
Journal:  Oncotarget       Date:  2015-05-20

4.  Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction.

Authors:  Jianzhong Li; Yuan Gui; Jiafa Ren; Xin Liu; Ye Feng; Zhifeng Zeng; Weichun He; Junwei Yang; Chunsun Dai
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

5.  Metformin inhibits SUV39H1-mediated migration of prostate cancer cells.

Authors:  T Yu; C Wang; J Yang; Y Guo; Y Wu; X Li
Journal:  Oncogenesis       Date:  2017-05-01       Impact factor: 7.485

6.  Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats.

Authors:  Maysa A Mobasher; Mousa O Germoush; Hala Galal El-Tantawi; Karim Samy El-Said
Journal:  Pathogens       Date:  2021-01-11

7.  PD-1-siRNA Delivered by Attenuated Salmonella Enhances the Antitumor Effect of Chloroquine in Colon Cancer.

Authors:  Shuya Lu; Jianhui Gao; Huijie Jia; Yang Li; Yongbin Duan; Fuyang Song; Zhiang Liu; Shuai Ma; Mingyong Wang; Tiesuo Zhao; Jiateng Zhong
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

8.  PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery.

Authors:  Yi Zhao; Wei Wang; Shutao Guo; Yuhua Wang; Lei Miao; Yang Xiong; Leaf Huang
Journal:  Nat Commun       Date:  2016-06-06       Impact factor: 14.919

9.  Effects of glabridin combined with 5-fluorouracil on the proliferation and apoptosis of gastric cancer cells.

Authors:  Lei Zhang; Hongmei Chen; Mingfei Wang; Xiaojing Song; Fanghui Ding; Jun Zhu; Xun Li
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

10.  CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer.

Authors:  Tongyuan Deng; Peng Shen; Aimin Li; Ziyan Zhang; Huiling Yang; Xiaojie Deng; Xuemei Peng; Zhe Hu; Zibo Tang; Jiahao Liu; Rentao Hou; Zhen Liu; Weiyi Fang
Journal:  Theranostics       Date:  2021-07-13       Impact factor: 11.556
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.